Form D · Biotechnology
Nyra Medical, Inc.
Decatur, GA · CIK 0001955347
Offering snapshot reported Nov 21, 2022 · SEC filing
- Reported sold
- $12M Offering amount: $20M
- Investors reported
- 14 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 10, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 21, 2022 | Initial | $11,999,977 | No comparison | 14 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-465398
Source: Form D, filed Nov 21, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Lisa Wipperman Heine | Director |
| Sai Muralidhar Padala | Director, Executive |
| Gowri Raman | Director |
| Eric Sarin | Director |
| Amrinder Singh | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
2459 Oak Grove Heights
Decatur, GA, 30033
Decatur, GA, 30033